Sign in

KNTE on NASDAQ

Kinnate Biopharma Inc.

Kinnate Biopharma Inc. is an oncology therapeutics company.1 Its shares trade on NASDAQ under the symbol KNTE.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

See how the biggest companies compare on our leaderboards

Corporate structure

Kinnate Biopharma Inc. is part of a group headed by XOMA Royalty Corp. 14 entities, 5 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • XOMA Royalty Corp Emeryville, California
    • Kinnate Biopharma Inc.
    • Generation Bio Co. Subsidiary · Delaware, United States
    • Generation Bio Securities Corp. Subsidiary · Massachusetts, United States
    • HilleVax, Inc. Subsidiary · Delaware, United States
    • LAVA Therapeutics New Topco B.V. Subsidiary · Netherlands
    • Mural Oncology plc Subsidiary · Ireland
    • Pulmokine, Inc. Subsidiary · Delaware, United States
    • Turnstone Biologics Corp. Subsidiary · Delaware, United States
    • XOMA (US) LLC Subsidiary · Delaware, United States
    • XOMA Technology Ltd. Subsidiary · Bermuda
    • XOMA UK Limited Subsidiary · United Kingdom
    • XRA 5 Corp. Subsidiary · Delaware, United States
    • XRL 1 LLC Subsidiary · Delaware, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Timeline

  1. 2020Went public Listed on NASDAQ1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1